Surfactant Protein-A Protects against IL-13–Induced Inflammation in Asthma

Genetic Variation in Surfactant Protein-A2 Delays Resolution of Eosinophilia in Asthma

(2019) Alane Blythe C. Dy et al.   JOURNAL OF IMMUNOLOGY

Obese asthmatic patients have decreased surfactant protein A levels: Mechanisms and implications

(2018) Njira Lugogo et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Macrophage function in tissue repair and remodeling requires IL-4 or IL-13 with apoptotic cells

(2017) Lidia Bosurgi et al.   SCIENCE

STAT3 inhibition prevents lung inflammation, remodeling, and accumulation of Th2 and Th17 cells in a murine asthma model

(2016) A. C. Gavino et al.   ALLERGY

Targeting the JAK-STAT pathway in the treatment of ‘Th2-high’ severe asthma

(2016) Kara Vale   Future Medicinal Chemistry

A Novel Small-Molecule Inhibitor Targeting the IL-6 Receptor β Subunit, Glycoprotein 130

(2015) Soon-Sun Hong et al.   JOURNAL OF IMMUNOLOGY

Genetic Variation inSP-A2Leads to Differential Binding toMycoplasma pneumoniaeMembranes and Regulation of Host Responses

(2015) Julie G. Ledford et al.   JOURNAL OF IMMUNOLOGY

STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor

(2013) Y. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Differential effects of interleukin-13 and interleukin-6 on Jak/STAT signaling and cell viability in pancreatic β-cells

(2013) Mark A. Russell et al.   Islets

Severe asthma: from characteristics to phenotypes to endotypes

(2012) S. Wenzel   CLINICAL AND EXPERIMENTAL ALLERGY

IL-4 and IL-13 employ discrete signaling pathways for target gene expression in alternatively activated monocytes/macrophages

(2012) Ashish Bhattacharjee et al.   FREE RADICAL BIOLOGY AND MEDICINE

Surfactant Protein-A Suppresses Eosinophil-Mediated Killing of Mycoplasma pneumoniae in Allergic Lungs

(2012) Julie G. Ledford et al.   PLoS One

Surfactant protein A is defective in abrogating inflammation in asthma

(2011) Ying Wang et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Airway Fibroblasts in Asthma Manifest an Invasive Phenotype

(2011) Jennifer L. Ingram et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Lung Effector Memory and Activated CD4+ T Cells Display Enhanced Proliferation in Surfactant Protein A-Deficient Mice during Allergen-Mediated Inflammation

(2011) A. M. Pastva et al.   JOURNAL OF IMMUNOLOGY

Interleukin-13–Induced Mucous Metaplasia Increases Susceptibility of Human Airway Epithelium to Rhinovirus Infection

(2010) Marrah E. Lachowicz-Scroggins et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

IL-13 suppresses double-stranded RNA-induced IFN-λ production in lung cells

(2010) Atsushi Moriwaki et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Both Hematopoietic-Derived and Non–Hematopoietic-Derived β-Arrestin–2 Regulates Murine Allergic Airway Disease

(2009) John W. Hollingsworth et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype

(2009) R. H. Dougherty et al.   CLINICAL AND EXPERIMENTAL ALLERGY

IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells

(2008) K. Chibana et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Mycoplasma pneumoniae induces airway epithelial cell expression of MUC5AC in asthma

(2008) M. Kraft et al.   EUROPEAN RESPIRATORY JOURNAL

Distinct roles for IL-13 and IL-4 via IL-13 receptor  1 and the type II IL-4 receptor in asthma pathogenesis

(2008) A. Munitz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA